- Interstitial lung diseases in children (Review of Foreign Literature). Part 1. ILD disease entities, which are found mainly in infants (0-2 years)
Interstitial lung diseases in children (Review of Foreign Literature). Part 1. ILD disease entities, which are found mainly in infants (0-2 years)
SOVREMENNAYA PEDIATRIYA.2016.2(74):46-55; doi 10.15574/SP.2016.74.46
Interstitial lung diseases in children (Review of Foreign Literature). Part 1. ILD disease entities, which are found mainly in infants (0-2 years)
Okhotnikova O. M., Tkacheva T. N., Gorbatyuk O. I.
The National Academy of Postgraduate Education, Kyiv, Ukraine
Interstitial lung disease (ILD) in infants and children comprises a large spectrum of rare respiratory disorders that are mostly chronic and associated with high morbidity and mortality. These disorders are characterized by inflammatory and fibrotic changes that affect alveolar walls. Children with these conditions typically present with tachypnea, crackles, and hypoxemia. Recent advances have been made in the identification of different types of PILD that are unique to infancy. More exciting has been the discovery of genetic abnormalities of surfactant function, now described in both children and adults. Several classifications for ILD have been proposed but none is entirely satisfactory especially in children. The following diagnostic grouping is used to discuss the various causes of paediatric ILD: 1) exposure-related ILD; 2) systemic disease-associated ILD; 3) alveolar structure disorder-associated ILD; and 4) ILD specific to infancy. The present article reviews different types of PILD, current diagnostic approaches, as well as therapeutic strategies. The article is divided into three parts. The first part describes the ILD disease entities, which are found mainly in infants; Part 2 is devoted to the diseases in older children (2–18 years), in which the clinic has a chronic pulmonary parenchymal process; in the third part provides information on the methods and approaches of diagnosis as well as treatment strategies.
Key words: Interstitial lung disease, children, classifications, diagnostics, treatment.
REFERENCES
1. American Thoracic Society, European Respiratory Society. Joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS). American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002, 165: 277–304.
2. An official European Respiratory Society/American Thoracic Society researchstatement: interstitial pneumonia withautoimmune features:ERJ Express. Published on July 9, 2015.
3. An Official American Thoracic Society Clinical PracticeGuideline: Classification, Evaluation, and Managementof Childhood Interstitial Lung Disease in Infancy Am J Respir Crit Care Med. 2013, Aug 1, 188; 3: 376–394. http://dx.doi.org/10.1164/rccm.201305-0923ST; PMid:23905526 PMCid:PMC3778735
4. Clement A, Nathan N, Eraund R. 2010. Interstitial lung diseases in children. Orphanet Jounal of Rare Diseases. 5: 22. http://dx.doi.org/10.1186/1750-1172-5-22; PMid:20727133 PMCid:PMC2939531
5. Clement A, Eber E. 2008. Interstitial lung diseases in infants and children. Eur Respir J. 31(3): 658–66. http://dx.doi.org/10.1183/09031936.00004707; PMid:18310399
6. Bush A, Nicholson AG. 2009. Pediatric Interstitial lung diseases. Eur respir Mon. 48: 319–364.
7. Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA et al. 2007. Diffuse lung disease in young children: application of a novelclassification scheme. Am J Respir Crit Care Med. 176(11): 1120–8. http://dx.doi.org/10.1164/rccm.200703-393oc
8. Fan LL, Langston C. 2002. Pediatric interstitial lung disease: children are notsmall adults. Am J Respir Crit Care Med. 165(11): 1466–7. http://dx.doi.org/10.1164/rccm.2204012; PMid:12045116
9. Fan LL, Deterding RR, Claire Langston 2004: Peadiatric Interstitial lung diseasesresided. Pediatric Pulmonology. 38: 369–378.
10. Maria Aparecida Soares de Souza Paiva et al. 2009. Chronic interstitial lung diseases in children.J.Bras. Pulmon. 35 (8): 792–803.
11. Meyer KC, Raghu G, Baughman RP et al. 2012. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolarlavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 185 (9): 1004–1014. http://dx.doi.org/10.1164/rccm.201202-0320ST; PMid:22550210